These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 6205005)

  • 1. Possible epigenetic mechanisms of tumor progression: induction of high-frequency heritable but phenotypically unstable changes in the tumorigenic and metastatic properties of tumor cell populations by 5-azacytidine treatment.
    Kerbel RS; Frost P; Liteplo R; Carlow DA; Elliott BE
    J Cell Physiol Suppl; 1984; 3():87-97. PubMed ID: 6205005
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selection of strongly immunogenic "tum-" variants from tumors at high frequency using 5-azacytidine.
    Frost P; Liteplo RG; Donaghue TP; Kerbel RS
    J Exp Med; 1984 May; 159(5):1491-501. PubMed ID: 6201588
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lack of correlation between DNA-methylating activity and appearance of the immunogenic phenotype in clones of a murine lymphoma treated with mutagens.
    Fuschiotti P; Fioretti MC; Romani L; Puccetti P
    Cancer Immunol Immunother; 1989; 29(2):139-43. PubMed ID: 2470506
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in the tumorigenic and metastatic properties of tumor cells treated with quercetin or 5-azacytidine.
    Ishikawa M; Okada F; Hamada J; Hosokawa M; Kobayashi H
    Int J Cancer; 1987 Mar; 39(3):338-42. PubMed ID: 2434441
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of a nonexpressed hypoxanthine phosphoribosyltransferase allele in mutant H23 HeLa cells by agents that inhibit DNA methylation.
    Ivarie R; Morris JA
    Mol Cell Biol; 1986 Jan; 6(1):97-104. PubMed ID: 2431268
    [TBL] [Abstract][Full Text] [Related]  

  • 6. On the possible contribution of DNA hypomethylation to the induction of high frequency and heritable drug-induced alterations in the malignant phenotype.
    Kerbel RS; Liteplo R; Frost P
    Prog Clin Biol Res; 1986; 212():293-304. PubMed ID: 2424028
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of mutagens on the immunogenicity of tumor cells: comparison of cell surface changes induced by 5-azacytidine and N-methyl-N'-nitro-N-nitrosoguanidine.
    Altevogt P
    Cancer Res; 1986 Jun; 46(6):2912-6. PubMed ID: 2421887
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selection of metastatic variants with identifiable karyotypic changes from a nonmetastatic murine tumor after treatment with 2'-deoxy-5-azacytidine or hydroxyurea: implications for the mechanisms of tumor progression.
    Frost P; Kerbel RS; Hunt B; Man S; Pathak S
    Cancer Res; 1987 May; 47(10):2690-5. PubMed ID: 2436755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heritable high frequency modulation of antigen expression in neoplastic cells exposed to 5-aza-2'-deoxycytidine or hydroxyurea: analysis and implications.
    Alvarez E; Elliott BE; Houghton AN; Kerbel RS
    Cancer Res; 1988 May; 48(9):2440-5. PubMed ID: 2451561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modification of the metastatic potential of tumor cells by drugs.
    Takenaga K
    Cancer Metastasis Rev; 1986; 5(2):67-75. PubMed ID: 2435428
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In situ augmentation of class I major histocompatibility antigen expression on immunogenic variants of a spontaneous murine mammary carcinoma.
    Elliott BE; Carlow DA; Ivimey L; Arnold M; Hampton N; Bosman P
    Cancer Res; 1987 Sep; 47(18):4915-23. PubMed ID: 2441856
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metastatic phenotype of human prostate tumor cells in athymic nude mice: alteration by exposure to ethyl methanesulfonate and "reversion" by 5-azacytidine.
    Ware JL; Lieberman AP; Webb KS
    Cancer Immunol Immunother; 1986; 21(1):58-62. PubMed ID: 2417701
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced expression of class I major histocompatibility complex gene (Dk) products on immunogenic variants of a spontaneous murine carcinoma.
    Carlow DA; Kerbel RS; Feltis JT; Elliott BE
    J Natl Cancer Inst; 1985 Aug; 75(2):291-301. PubMed ID: 2410653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clonal analysis of the malignant properties of B16 melanoma cells treated with the DNA hypomethylating agent 5-azacytidine.
    Trainer DL; Kline T; Hensler G; Greig R; Poste G
    Clin Exp Metastasis; 1988; 6(3):185-200. PubMed ID: 2450714
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of invasive and metastatic potential in mouse T-lymphoma cells (BW5147) by treatment with 5-azacytidine.
    Habets GG; van der Kammen RA; Scholtes EH; Collard JG
    Clin Exp Metastasis; 1990; 8(6):567-77. PubMed ID: 1699692
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clonal variation in the impact of ethyl methanesulfonate and 5-azacytidine on the metastatic phenotype of human prostatic tumor cells in athymic nude mice.
    Ware JL
    Exp Cell Biol; 1988; 56(5):270-6. PubMed ID: 2465929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunological characteristics of immunogenic variants induced in the MCA-F murine fibrosarcoma using 1-methyl-3-nitro-1-nitrosoguanidine, 5-aza-2'-deoxycytidine, or ultraviolet radiation.
    Simcik W; Frost P; LeGrue SJ
    Cancer Res; 1989 Aug; 49(15):4192-8. PubMed ID: 2472875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of 5-azacytidine on malignant transformation of a mutant derived from the mouse BALB/c 3T3 cell line resistant to transformation by chemical carcinogens.
    Yasutake C; Kuratomi Y; Ono M; Masumi S; Kuwano M
    Cancer Res; 1987 Sep; 47(18):4894-9. PubMed ID: 2441855
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long term instability and molecular mechanism of 5-azacytidine-induced DNA hypomethylation in normal and neoplastic tissues in vivo.
    Lu LJ; Randerath K
    Mol Pharmacol; 1984 Nov; 26(3):594-603. PubMed ID: 6208475
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-frequency generation of altered Mr 70,000 env glycoproteins in N-methyl-N'-nitro-N-nitrosoguanidine-treated murine tumor cells.
    Altevogt P; Apt D
    Cancer Res; 1988 Mar; 48(5):1137-42. PubMed ID: 3342395
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.